Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation (GENEPSO)

Institut Paoli-Calmettes

Status: Enrolling

Conditions: Breast Cancers; Ovarian Cancers

Treatments: Other: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT03667417

GENEPSO-IPC 2018-031

Details and patient eligibility

About

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Full description

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

1. Woman or man, with or without cancer, carrying a deleterious BRCA1/BRCA2 mutation, aged 18 years and over.

   1. Woman with or without breast cancer or ovarian cancer at baseline.
   2. Man with or without breast cancer at baseline.

2. Signed consent to participation

3. Affiliation to a social security regimen, or beneficiary of such a regimen.

Exclusion Criteria:

1. A person of legal age subject to a legal protection measure, or unable to express consent.
2. Impossibility to submit to the follow-up of the test for geographical, social or psychological reasons

Trial design

5,000 participants in 1 patient group

subjects carrying a BRCA gene mutation

Description:

subjects carrying a BRCA gene mutation

Treatment:

Other: Questionnaires